Validated across a wide range of peer-reviewed publications

We work with forward-looking researchers to demonstrate the clinical value of our solutions to patients, clinicians and the risk-bearing payors such as health plans and accountable care organizations (ACOs) that support them.

Clinical Evidence

Engagement, patient experience and reported outcomes in monitoring severe asthma with initiated biologics
High engagement in remote monitoring with personalized support for people with COPD
High data quality and adherence in remote asthma diagnosis assessment program
High quality of NuvoAir spirometry in children with CF
High adherence rates to daily and weekly spirometry in ILD patients
Clinical effectiveness and validity of NuvoAir home spirometry in children with cystic fibrosis
Real-world study shows Air Next comparable to office spirometry for children with asthma
NuvoAir spirometry FEV1 data predicts asthma exacerbations
AstraZeneca real-world evidence study for a severe asthma treatment uses NuvoAir to monitor and assess lung function
NuvoAir resulted in high adherence, high reliability and high concordance with hospital-based spirometry in Boston Children's Hospital study
Boston Children's Hospital finds high reliability and good concordance to in-clinic testing with children with CF
CF patients and clinicians report time savings with home spirometry
Study in Italy with virtual care with NuvoAir for CF shows reduction in exacerbations
CF patients report improved consultations with providers and understanding of their condition
COPD members are highly engaged when supported by care coordinators in NuvoAir Virtual-First Care
Regeneron observational study used NuvoAir to monitor effects of allergen exposure on asthma patients
Improved clinical outcomes seen with long-term use of the NuvoAir Home platform
Patients and clinicians in England-wide survey report high value and trust with NuvoAir Home to detect changes in lung function and monitor lung health
NuvoAir Cough app shows precision rate of 84% in detecting coughs
Improved attendance rates and reduced hospital admission rates with virtual clinics supported by NuvoAir Home for patients with difficult asthma
Adults with severe asthma perform high quality unsupervised home spirometry with NuvoAir
High acceptability of NuvoAir home monitoring with pediatric asthma patients at Royal Brompton Hospital
Quality and high adherence to NuvoAir Home shows promise for long-term monitoring of pediatric asthma
NuvoAir supports home administration of biologics for pediatric severe asthma
NuvoAir Home respiratory platform supports remote monitoring of asthma patients
Unsupervised home spirometry with the platform is found equivalent to in-clinic spirometry
NuvoAir with unsupervised in-app coaching meets ATS/ERS repeatability criteria for both pediatric CF and bronchiectasis patients
Swedish pilot shows technology can be used at home by children with CF with postive experience of virtual clinics
Proven effective in driving virtual consultations during an 18-month patient research
Pilot Study with Göteborg, Respiratory Medicine confirms NuvoAir Platform well complements CF care
NuvoAir Reduced Booked and Urgent Face to Face Consultations in Cystic Fibrosis Patients
Pilot study with Royal Brompton Hospital suggests NuvoAir platform may improve Cystic Fibrosis outcomes

Real-World-Data from our engagements reveals great health economic outcome potential and staggering acceptance

9.4 - Acceptance of NuvoAir solution on a scale from 0 to 10



Improved understanding
of their condition

medication adherence

ePS1.07 Patient experience of virtual consultations: survey results, Journal of Cystic Fibrosis Volume 19, Supplement 2, June 2020, Page s39

Seattle Children's Hospital
InterMedCon Gmbh
University os Ioannina
Boston Children's Hospital
King's College
Guy's and St. Thomas